annual FCF:
$47.06M-$53.38M(-53.15%)Summary
- As of today (May 21, 2025), ANIP annual free cash flow is $47.06 million, with the most recent change of -$53.38 million (-53.15%) on December 31, 2024.
- During the last 3 years, ANIP annual FCF has risen by +$67.38 million (+331.66%).
- ANIP annual FCF is now -53.15% below its all-time high of $100.45 million, reached on December 31, 2023.
Performance
ANIP Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$15.14M+$1.76M(+13.19%)Summary
- As of today (May 21, 2025), ANIP quarterly free cash flow is $15.14 million, with the most recent change of +$1.76 million (+13.19%) on March 31, 2025.
- Over the past year, ANIP quarterly FCF has increased by +$1.46 million (+10.64%).
- ANIP quarterly FCF is now -62.10% below its all-time high of $39.96 million, reached on December 31, 2023.
Performance
ANIP quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$48.52M+$1.46M(+3.10%)Summary
- As of today (May 21, 2025), ANIP TTM free cash flow is $48.52 million, with the most recent change of +$1.46 million (+3.10%) on March 31, 2025.
- Over the past year, ANIP TTM FCF has dropped by -$46.54 million (-48.96%).
- ANIP TTM FCF is now -51.70% below its all-time high of $100.45 million, reached on December 31, 2023.
Performance
ANIP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ANIP Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -53.1% | +10.6% | -49.0% |
3 y3 years | +331.7% | +171.7% | +179.1% |
5 y5 years | +160.3% | +127.1% | +252.8% |
ANIP Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -53.1% | +198.8% | -62.1% | +171.7% | -51.7% | +179.1% |
5 y | 5-year | -53.1% | +188.7% | -62.1% | +127.1% | -51.7% | +179.1% |
alltime | all time | -53.1% | +138.7% | -62.1% | +120.3% | -51.7% | +133.4% |
ANIP Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $15.14M(+13.2%) | $48.52M(+3.1%) |
Dec 2024 | $47.06M(-53.1%) | $13.38M(+90.3%) | $47.06M(-36.1%) |
Sep 2024 | - | $7.03M(-45.8%) | $73.64M(-21.8%) |
Jun 2024 | - | $12.96M(-5.3%) | $94.23M(-0.9%) |
Mar 2024 | - | $13.69M(-65.7%) | $95.06M(-5.4%) |
Dec 2023 | $100.45M(-310.8%) | $39.96M(+44.7%) | $100.45M(+89.7%) |
Sep 2023 | - | $27.62M(+100.1%) | $52.95M(+176.6%) |
Jun 2023 | - | $13.80M(-27.6%) | $19.14M(-356.3%) |
Mar 2023 | - | $19.07M(-352.9%) | -$7.47M(-84.3%) |
Dec 2022 | -$47.66M(+134.6%) | -$7.54M(+21.8%) | -$47.66M(-9.5%) |
Sep 2022 | - | -$6.19M(-51.7%) | -$52.67M(+0.4%) |
Jun 2022 | - | -$12.80M(-39.4%) | -$52.46M(-14.5%) |
Mar 2022 | - | -$21.12M(+68.2%) | -$61.37M(+202.1%) |
Dec 2021 | -$20.32M(-61.7%) | -$12.55M(+109.7%) | -$20.32M(+30.3%) |
Sep 2021 | - | -$5.99M(-72.4%) | -$15.59M(-8.4%) |
Jun 2021 | - | -$21.71M(-208.9%) | -$17.03M(-175.0%) |
Mar 2021 | - | $19.93M(-354.6%) | $22.71M(-142.8%) |
Dec 2020 | -$53.05M(-393.4%) | -$7.83M(+5.5%) | -$53.05M(+26.9%) |
Sep 2020 | - | -$7.42M(-141.2%) | -$41.80M(+188.0%) |
Jun 2020 | - | $18.03M(-132.3%) | -$14.51M(-54.3%) |
Mar 2020 | - | -$55.84M(-1728.3%) | -$31.76M(-275.6%) |
Dec 2019 | $18.08M(-67.8%) | $3.43M(-82.7%) | $18.08M(-55.8%) |
Sep 2019 | - | $19.86M(+2426.8%) | $40.88M(+46.2%) |
Jun 2019 | - | $786.00K(-113.1%) | $27.96M(-5.3%) |
Mar 2019 | - | -$5.99M(-122.9%) | $29.52M(-47.4%) |
Dec 2018 | $56.16M(-181.9%) | $26.23M(+277.5%) | $56.16M(-1384.3%) |
Sep 2018 | - | $6.95M(+197.1%) | -$4.37M(-233.2%) |
Jun 2018 | - | $2.34M(-88.7%) | $3.28M(-342.0%) |
Mar 2018 | - | $20.65M(-160.2%) | -$1.36M(-98.0%) |
Dec 2017 | -$68.57M(-43.6%) | -$34.31M(-334.9%) | -$68.57M(+190.9%) |
Sep 2017 | - | $14.60M(-734.1%) | -$23.57M(-38.3%) |
Jun 2017 | - | -$2.30M(-95.1%) | -$38.18M(-59.2%) |
Mar 2017 | - | -$46.56M(-535.5%) | -$93.57M(-23.0%) |
Dec 2016 | -$121.59M(+688.6%) | $10.69M(<-9900.0%) | -$121.59M(-5.5%) |
Sep 2016 | - | -$5000.00(-100.0%) | -$128.68M(-11.4%) |
Jun 2016 | - | -$57.69M(-22.6%) | -$145.21M(+67.9%) |
Mar 2016 | - | -$74.58M(-2173.5%) | -$86.51M(+461.1%) |
Dec 2015 | -$15.42M(+12.4%) | $3.60M(-121.8%) | -$15.42M(+79.0%) |
Sep 2015 | - | -$16.53M(-1740.1%) | -$8.61M(-17.6%) |
Jun 2015 | - | $1.01M(-128.9%) | -$10.45M(+7.1%) |
Mar 2015 | - | -$3.49M(-133.6%) | -$9.76M(-28.9%) |
Dec 2014 | -$13.72M(+141.8%) | $10.40M(-156.6%) | -$13.72M(-49.2%) |
Sep 2014 | - | -$18.37M(-1179.9%) | -$27.02M(+162.0%) |
Jun 2014 | - | $1.70M(-122.8%) | -$10.31M(+14.8%) |
Mar 2014 | - | -$7.46M(+157.6%) | -$8.99M(+58.3%) |
Dec 2013 | -$5.67M(-78.1%) | -$2.89M(+73.8%) | -$5.67M(-5.9%) |
Sep 2013 | - | -$1.67M(-155.0%) | -$6.03M(-50.6%) |
Jun 2013 | - | $3.03M(-173.1%) | -$12.21M(-45.2%) |
Mar 2013 | - | -$4.15M(+27.7%) | -$22.30M(-13.9%) |
Dec 2012 | -$25.89M | -$3.25M(-58.6%) | -$25.89M(-23.0%) |
Sep 2012 | - | -$7.85M(+11.2%) | -$33.65M(-12.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | -$7.06M(-8.9%) | -$38.48M(-15.7%) |
Mar 2012 | - | -$7.74M(-29.6%) | -$45.64M(-6.1%) |
Dec 2011 | -$48.59M(+21.0%) | -$11.00M(-13.3%) | -$48.59M(-6.2%) |
Sep 2011 | - | -$12.69M(-10.7%) | -$51.83M(+3.7%) |
Jun 2011 | - | -$14.21M(+32.9%) | -$50.00M(+11.9%) |
Mar 2011 | - | -$10.69M(-24.9%) | -$44.69M(+11.3%) |
Dec 2010 | -$40.16M(+116.0%) | -$14.24M(+31.1%) | -$40.16M(+25.2%) |
Sep 2010 | - | -$10.86M(+22.0%) | -$32.07M(+28.6%) |
Jun 2010 | - | -$8.90M(+44.2%) | -$24.94M(+23.8%) |
Mar 2010 | - | -$6.17M(+0.3%) | -$20.15M(+8.4%) |
Dec 2009 | -$18.60M(+14.9%) | -$6.15M(+64.9%) | -$18.60M(+21.5%) |
Sep 2009 | - | -$3.73M(-9.2%) | -$15.30M(-13.2%) |
Jun 2009 | - | -$4.11M(-11.0%) | -$17.63M(-3.8%) |
Mar 2009 | - | -$4.61M(+61.5%) | -$18.32M(+13.2%) |
Dec 2008 | -$16.19M(-2377.9%) | -$2.86M(-52.8%) | -$16.19M(+34.3%) |
Sep 2008 | - | -$6.06M(+26.2%) | -$12.06M(+49.4%) |
Jun 2008 | - | -$4.80M(+93.9%) | -$8.07M(+51.7%) |
Mar 2008 | - | -$2.47M(-294.1%) | -$5.32M(-848.7%) |
Dec 2007 | $710.60K(-114.1%) | $1.27M(-161.5%) | $710.50K(+15.5%) |
Sep 2007 | - | -$2.07M(+1.3%) | $615.40K(-52.9%) |
Jun 2007 | - | -$2.05M(-157.6%) | $1.31M(+61.3%) |
Mar 2007 | - | $3.56M(+201.3%) | $809.70K(-116.1%) |
Dec 2006 | -$5.04M(-39.8%) | $1.18M(-185.4%) | -$5.04M(-32.1%) |
Sep 2006 | - | -$1.38M(-45.7%) | -$7.41M(-5.0%) |
Jun 2006 | - | -$2.54M(+11.0%) | -$7.80M(-2.2%) |
Mar 2006 | - | -$2.29M(+91.2%) | -$7.98M(-4.6%) |
Dec 2005 | -$8.36M(-20.7%) | -$1.20M(-32.4%) | -$8.37M(-21.8%) |
Sep 2005 | - | -$1.77M(-34.7%) | -$10.70M(-8.3%) |
Jun 2005 | - | -$2.72M(+1.5%) | -$11.67M(+2.7%) |
Mar 2005 | - | -$2.68M(-24.3%) | -$11.36M(+7.7%) |
Dec 2004 | -$10.55M(+90.7%) | -$3.53M(+29.0%) | -$10.55M(+25.6%) |
Sep 2004 | - | -$2.74M(+13.7%) | -$8.40M(+15.7%) |
Jun 2004 | - | -$2.41M(+29.3%) | -$7.26M(+22.5%) |
Mar 2004 | - | -$1.86M(+34.4%) | -$5.92M(+7.1%) |
Dec 2003 | -$5.53M(+38.2%) | -$1.39M(-13.3%) | -$5.53M(+23.9%) |
Sep 2003 | - | -$1.60M(+48.8%) | -$4.47M(+17.6%) |
Jun 2003 | - | -$1.07M(-27.0%) | -$3.80M(-8.2%) |
Mar 2003 | - | -$1.47M(+358.6%) | -$4.14M(+3.3%) |
Dec 2002 | -$4.00M(+109.4%) | -$321.00K(-65.5%) | -$4.00M(-21.0%) |
Sep 2002 | - | -$929.30K(-34.2%) | -$5.07M(+60.4%) |
Jun 2002 | - | -$1.41M(+5.6%) | -$3.16M(+28.3%) |
Mar 2002 | - | -$1.34M(-3.4%) | -$2.46M(+28.8%) |
Dec 2001 | -$1.91M(-40.2%) | -$1.38M(-241.5%) | -$1.91M(+75.1%) |
Sep 2001 | - | $978.50K(-236.6%) | -$1.09M(-60.6%) |
Jun 2001 | - | -$716.50K(-9.1%) | -$2.77M(-21.2%) |
Mar 2001 | - | -$787.80K(+39.4%) | -$3.51M(+9.9%) |
Dec 2000 | -$3.19M(+78.2%) | -$565.20K(-18.8%) | -$3.19M(+21.5%) |
Sep 2000 | - | -$696.20K(-52.3%) | -$2.63M(+36.0%) |
Jun 2000 | - | -$1.46M(+208.8%) | -$1.93M(+308.8%) |
Mar 2000 | - | -$472.50K | -$472.50K |
Dec 1999 | -$1.79M(-43.4%) | - | - |
Dec 1998 | -$3.17M | - | - |
FAQ
- What is ANI Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual FCF year-on-year change?
- What is ANI Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly FCF year-on-year change?
- What is ANI Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM FCF year-on-year change?
What is ANI Pharmaceuticals annual free cash flow?
The current annual FCF of ANIP is $47.06M
What is the all time high annual FCF for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual free cash flow is $100.45M
What is ANI Pharmaceuticals annual FCF year-on-year change?
Over the past year, ANIP annual free cash flow has changed by -$53.38M (-53.15%)
What is ANI Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ANIP is $15.14M
What is the all time high quarterly FCF for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly free cash flow is $39.96M
What is ANI Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ANIP quarterly free cash flow has changed by +$1.46M (+10.64%)
What is ANI Pharmaceuticals TTM free cash flow?
The current TTM FCF of ANIP is $48.52M
What is the all time high TTM FCF for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM free cash flow is $100.45M
What is ANI Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ANIP TTM free cash flow has changed by -$46.54M (-48.96%)